Navigation Links
US Representative Mike Fitzpatrick Tours US BioDesign Manufacturing Facility

QUAKERTOWN, Pa., Sept. 6, 2013 /PRNewswire-iReach/ -- On August 28, Tom Molz, Founder and President of US BioDesign LLC, a premier supplier of implantable biomedical textile components to the global medical device industry, led civic and business leaders including US Representative Mike Fitzpatrick on a tour of the company's newly relocated offices and manufacturing facility in Quakertown, Pennsylvania. Congressman Fitzpatrick congratulated US BioDesign's commitment to expanding local manufacturing job opportunities. Pennsylvania Senator Bob Mensch also cited the company's commitment to manufacturing excellence and fostering regional economic growth.


The tour spotlighted US BioDesign's highly specialized capabilities, clean room technology and state-of-the-art manufacturing equipment, which includes the world's largest medical braider and custom-designed processes for non-woven medical felts. According to Mr. Molz, the facility expansion supports the company's business strategy for remaining competitive, despite the Affordable Care Act's economic impact on the global medical device industry.

"The Affordable Care Act mandates a 2.3% tax on the sale of medical devices which means our customers have to do more with less," said Keith Smith, Director of Business Development.  "Our streamlined approach to new product development enables the most cost effective use of resources, helping medical device companies address this challenge," he continued.

According to Mr. Molz, unlike some long established suppliers to the medical device industry, US BioDesign is a new company with an agile and flexible operating structure designed to support its singular founding mission: To serve the medical device industry as a highly capable, yet cost efficient supplier of engineered medical textiles, biomedical structures and implantable fabrics.  "Our business strategy," he said, "advances that mission and positions US BioDesign as the foremost industry resource for expert, highly reliable, highly capable, high quality yet cost efficient medical fabric development and manufacturing solutions."

"What you see is what you get - a smart, competitive company with an operating structure that's only as big as it needs to be, and agile and flexible enough to respond to changing industry dynamics without compromising quality or cost efficiency," commented Mr. Smith.

US BioDesign employees combine some 100 years of expertise in biomaterials and medical fabric design, development and manufacturing.  "The extensive medical device industry knowledge and expertise of our leadership and engineering teams can help medical device companies control R&D costs despite current and emerging economic challenges," said Mr. Molz.

US BioDesign Founder Tom Molz has driven discovery and innovation within the medical/biomedical textiles and implantable fabrics for medical devices industry for more than 20 years, and has been involved with biomedical textile developments in virtually all areas of the medical device industry. US BioDesign is the second biomedical manufacturing company founded by Mr. Molz.  Keith Smith brings extensive experience in bio-materials and textile structures used for implantable medical device components, in addition to leading business development and managing strategic client relationships for US BioDesign.

About US BioDesign

US BioDesign is a global leader in the development and manufacture of biomedical textile structures for medical devices across the cardiovascular, neurological and general surgery segments of the health care industry.   The company draws upon deep biomedical engineering expertise and an unparalleled understanding of medical device construct development involving polymeric and/or metallic raw materials to deliver elegant and efficient engineering solutions and commercial development support.  Founded in 2011, US BioDesign serves the global medical device industry, specializing in braided and non-woven components. 


US BioDesign LLC
Keith Smith, Director of Business Development
P: 267- 450-8860, x210

News distributed by PR Newswire iReach:

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. HemoShear Co-Founder Presents Recommendations for Funding of Breakthrough Technologies to U.S. House of Representatives Committee on Science, Engineering and Technology
2. PCMA: 88 U.S. Representatives Urge USPS to Preserve Six Day Delivery of Mail-Service Pharmacy
3. Doug Zitnak of Upsher-Smith Laboratories Named Small Brand Manufacturer Representative of the Year By Cardinal Health
4. Statement from the Cystic Fibrosis Foundation on Passage of the EXPERRT Act in House of Representatives
5. Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation
6. US BioDesign Relocation Expands Manufacturing Capabilities
7. Pharma Leader Series: Top Pharma Contract Manufacturing Organisations (CMOs) 2013-2023
8. Injectable Dose Formulations Highly Impact Global Pharmaceutical Contract Manufacturing Vendor Revenues
9. InspireMD Completes First Phase of Manufacturing Upgrade and Partners with HealthLink for Global Logistics and Distribution Services
10. China Orthopedic Devices Market, Contract Manufacturing in Orthopedic Industry Reports
11. European Union Grants a Good Manufacturing Practice Certificate to Nelson Laboratories
Post Your Comments:
(Date:11/24/2015)... , November 25, 2015 ... due to repeated failure of IVF cycles. After failure ... was totally dejected and had lost all hopes that she would be able ... Indian miracle child conceived after failure of over 15 ... abroad (UK) before they decided to take one last attempt with ...
(Date:11/24/2015)... SAN CARLOS, Calif. , Nov. 24, ... ), a leader in non-invasive genetic testing ... today announced that it will present at ... Conference in New York on Wednesday, December 2, 2015 at 1:00 p.m. ... discuss the Company,s financial results, business activities ...
(Date:11/24/2015)... /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") ... the first patient has been enrolled in ESSA,s Phase ... metastatic castration-resistant prostate cancer ("mCRPC"). the ... the United States and Canada.  ... trial, ESSA intends to demonstrate the safety, tolerability, maximum ...
Breaking Medicine Technology:
(Date:11/25/2015)... , ... November 25, 2015 , ... On November 10, ... States District Court of Connecticut on behalf of a home health care worker who ... current or former home health care workers employed by Humana, Inc., Humana at Home, ...
(Date:11/25/2015)... ... , ... On November 25, 2015, officials of Narconon Arrowhead , the ... of a new cutting edge recovery program that has been 50 years in the ... alcohol-addicted individuals with the purpose to free addicts from the symptoms and negative behaviors ...
(Date:11/25/2015)... ... , ... SCOTTSDALE, AZ) - Today, Dr. Todd C. ... and non-surgical treatments, announced the expansion of his private practice capabilities with the ... Highly trained and nationally recognized for his natural approach, Dr. Todd Hobgood serves ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Today, ... on our nation’s roadways has dropped below 10,000 for the first time since 2011. ... in 2013. , According to data released by the National Highway Traffic Safety Administration ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... of philanthropic seniors, is resulting in a way for homeless people to have ... Schaumburg have launched a new initiative whereby they are repurposing plastic bags into ...
Breaking Medicine News(10 mins):